BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 36 filers reported holding BOLT BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,364 | -18.7% | 79,196 | 0.0% | 0.00% | – |
| Q2 2023 | $101,370 | -53.5% | 79,196 | -49.5% | 0.00% | – |
| Q1 2023 | $218,042 | +113.8% | 156,866 | +100.0% | 0.00% | – |
| Q4 2022 | $101,970 | -12.8% | 78,439 | -1.0% | 0.00% | – |
| Q3 2022 | $117,000 | -27.8% | 79,265 | -0.6% | 0.00% | – |
| Q2 2022 | $162,000 | -25.7% | 79,762 | +0.2% | 0.00% | – |
| Q1 2022 | $218,000 | -97.0% | 79,631 | -94.7% | 0.00% | -100.0% |
| Q4 2021 | $7,325,000 | -79.4% | 1,494,955 | -46.9% | 0.00% | -66.7% |
| Q3 2021 | $35,602,000 | -18.8% | 2,814,383 | -0.8% | 0.00% | 0.0% |
| Q2 2021 | $43,856,000 | -53.7% | 2,836,686 | -1.4% | 0.00% | -62.5% |
| Q1 2021 | $94,683,000 | – | 2,877,034 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $29,242,000 | 11.52% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $18,041,000 | 5.60% |
| Novo Holdings A/S | 4,503,991 | $69,632,000 | 3.09% |
| Vivo Capital, LLC | 3,871,291 | $59,850,000 | 2.59% |
| Sofinnova Investments, Inc. | 2,754,437 | $42,584,000 | 2.45% |
| Ally Bridge Group (NY) LLC | 412,267 | $6,374,000 | 1.58% |
| Samsara BioCapital, LLC | 737,459 | $11,401,000 | 1.41% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $11,125,000 | 1.04% |
| RA Capital Management | 2,378,325 | $36,769,000 | 0.59% |
| Rock Springs Capital Management LP | 1,619,248 | $25,034,000 | 0.50% |